Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...
The new record from Lilly Hiatt, 'Forever', celebrates embracing the moment and seeking happiness in the haze, no matter how that may look or feel.
The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...
We catch up with the stellar singer-songwriter about the process of grounding herself that led to making her sixth album.
On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...
When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
Leerink notes Eli Lilly (LLY) terminated its volenrelaxin CKD due to failure of a “related heart failure study,” which has caused significant ...
The American Association of University Women of Iowa is celebrating the anniversary of a law aimed to fight pay ...
At the halfway point of the high school basketball season, Portland has a firm grip on the CAAC White title. Leading the way ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback